Be Aware of Toxicities From Immune Checkpoint Inhibitors
March 2024
You’ll get questions about adverse effects with immune checkpoint inhibitors (ICIs) as use increases.
Immune checkpoint inhibitors, such as pembrolizumab (Keytruda) or nivolumab (Opdivo), are a common type of cancer immunotherapy.
Cancer immunotherapy works by helping the patient’s immune system find and kill cancer cells. It’s different from chemotherapy, which directly targets dividing cells...malignant or healthy.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote